Company Overview of Kolltan Pharmaceuticals, Inc.
Key Executives for Kolltan Pharmaceuticals, Inc.
|Gerald McMahon Ph.D.||27 Relationships||Chief Executive Officer, President and Director||61|
|Arthur G. Altschul Jr.||39 Relationships||Co-Founder and Chairman of the Board||51|
|Joseph P. Schlessinger Ph.D.||70 Relationships||Co-Founder, Chairman of Scientific Advisory Board, Chief Scientist and Director||71|
|Jane Pritchett V. Henderson||14 Relationships||Chief Financial & Business Officer and Senior Vice President||50|
|Theresa M. Lavallee Ph.D.||No Relationships||Senior Vice President of Translational Medicine & Product Development||50|
|View More Key Executives|
Kolltan Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Arthur G. Altschul Jr.||39 Relationships||Kolltan Pharmaceuticals, Inc.||51|
|Gerald McMahon Ph.D.||27 Relationships||Kolltan Pharmaceuticals, Inc.||61|
|Axel Bolte M.Sc., M.B.A.||34 Relationships||HBM Partners Ltd.||44|
|Joseph P. Schlessinger Ph.D.||70 Relationships||Kolltan Pharmaceuticals, Inc.||71|
|K. Peter Hirth Ph.D.||94 Relationships||TrovaGene, Inc.||64|
Kolltan Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Advisory Board Ph.D.||Joseph P. Schlessinger||70 Relationships||8 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$400.0K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.